Skip to content

Development and Validation of a Novel Screening Tool for Early Detection of Developmental and Mood Disorders in Children and Adolescents

Development of a new screening tool for early diagnosis of developmental and mood disorders in children and adolescents - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082294
Enrollment
3300
Registered
2025-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type Health Condition 2: F949- Childhood disorder of social functioning, unspecified Health Condition 3: F939- Childhood emotional disorder, unspecified

Interventions

Intervention1: CogniScale (development and validation of a new screening tool for the early diagnosis of developmental, mood, and behavioral disorders in children): The study is structured into multip

Sponsors

Dr Shreenivas Rachakonda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 1 month to 18 years 2. Availability of a Primary Caregiver or Parent 3. Consent to Participate in the study and the follow up process

Exclusion criteria

Exclusion criteria: 1. Children diagnosed Severe Neurological Disorders: Children with epilepsy with uncontrolled seizures, or neurodegenerative disorders that significantly impair communication or cooperation in screening assessments. 2. Children with acute medical illness at the time of screening: Children who are hospitalized or have a severe acute illness at the time of screening will be excluded to avoid confounding effects on behavioral assessment. 3. Children with a prior diagnosis with a fully established psychiatric disorder and undergoing intensive treatment: If a child is already diagnosed with a psychiatric disorder (e.g., schizophrenia, severe bipolar disorder, major depressive disorder) and is undergoing intensive psychiatric treatment (hospitalization, psychotherapy, or multiple psychotropic medications), they may be excluded to prevent bias in validation. 4. Children with history of developmental regression due to organic causes: Children with documented progressive developmental regression due to metabolic or genetic syndromes that significantly impact cognitive and behavioral function. 5. Children with non-consent from Parent/Guardian

Design outcomes

Primary

MeasureTime frame
To develop and validate a novel screening tool for early detection of developmental, mood, and behavioral disorders in children and adolescents.Timepoint: 2 years

Secondary

MeasureTime frame
Prevalence of Developmental, Mood, and Behavioral Disorders in the Study PopulationTimepoint: 2 years

Countries

India

Contacts

Public ContactDr Lal DV

Saveetha Medical College and Hospital

drlaldv@gmail.com7299938038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026